Instaryl D Syrup is a combination pharmaceutical formulation containing Phenylephrine (5mg/5ml), Chlorpheniramine Maleate (2mg/5ml), and Dextromethorphan Hydrobromide (10mg/5ml), designed for the symptomatic relief of upper respiratory tract conditions. Phenylephrine acts as a selective alpha-1 adrenergic receptor agonist, providing effective nasal decongestion by vasoconstriction of the nasal mucosa. Chlorpheniramine Maleate, a first-generation antihistamine, alleviates allergic symptoms such as sneezing, rhinorrhea, and itching by antagonizing peripheral H1 histamine receptors. Dextromethorphan Hydrobromide serves as a centrally acting antitussive agent, suppressing the cough reflex through its action on the medullary cough center without causing significant respiratory depression. Instaryl D Syrup is indicated for the management of symptoms associated with common cold, allergic rhinitis, sinusitis, and other upper respiratory tract infections where nasal congestion, cough, and allergic manifestations coexist. The syrup formulation allows for ease of administration, particularly in pediatric and adult patients who require symptomatic relief. Caution is advised in patients with hypertension, glaucoma, or those on monoamine oxidase inhibitors. Use should be guided by a healthcare professional to ensure appropriate dosing and to minimize potential adverse effects and drug interactions.